Peter Landgraf

Peter Landgraf

Auto-generated profile, based on publicly available information

Peter Landgraf

Institute for Pharmacology and Toxicology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2025 in Cell
Verified
Journal Article
Open access
MWMarcel S. Woo
Marcel S. Woo
JBJohannes Brand
Johannes Brand
LBLukas C. Bal
Lukas C. Bal
MMManuela Moritz
Manuela Moritz
MWMark Walkenhorst
Mark Walkenhorst
MFManuel A. Friese
Manuel A. Friese
Inflammation, aberrant proteostasis, and energy depletion are hallmarks of neurodegenerative diseases such as multiple sclerosis (MS). However, the interplay between inflammation, proteasomal dysfunction in neurons, and its consequences for neuronal integrity remains unclear. Using transcriptional, proteomic, and functional analyses of proteasomal subunits in inflamed neurons, we found that interferon-γ-mediated induction of the immunoproteasome subunit, proteasome 20S beta 8 (PSMB8) impairs the proteasomal balance, resulting in reduced proteasome activity. This reduction causes the accumulation of phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), a key metabolic regulator, leading to enhanced neuronal glycolysis, reduced pentose phosphate pathway activity, oxidative injury, and ferroptosis. Neuron-specific genetic and systemic pharmacological targeting of PSMB8 or PFKFB3 protected neurons in vitro and in a mouse model of MS. Our findings provide a unifying explanation for proteasomal dysfunction in MS and possibly other neurodegenerative diseases, linking inflammation to metabolic disruption, and presenting an opportunity for targeted neuroprotective therapies.

19 November 2022 in Glia
Verified
Journal Article
Open access
PPPriyadharshini Prabhakar
Priyadharshini Prabhakar
RPRainer Pielot
Rainer Pielot
PLPeter Landgraf
Peter Landgraf
JWJosef Wissing
Josef Wissing
ABAnne Bayrhammer
Anne Bayrhammer
AMAnke Müller
Anke Müller
Astrocytes exhibit regional heterogeneity in morphology, function and molecular composition to support and modulate neuronal function and signaling in a region‐specific manner. To characterize regional heterogeneity of astrocytic proteomes of different brain regions we established an inducible Aldh1l1‐methionyl‐tRNA‐synthetaseL274G (MetRSL274G) mouse line that allows astrocyte‐specific metabolic labeling of newly synthesized proteins by azidonorleucine (ANL) in vivo and subsequent isolation of tagged proteins by click chemistry. We analyzed astrocytic proteins from four different brain regions by mass spectrometry. The induced expression of MetRSL274G is restricted to astrocytes and identified proteins show a high overlap with proteins compiled in “AstroProt,” a newly established database for astrocytic proteins. Gene enrichment analysis reveals a high similarity among brain regions with subtle differences in enriched biological processes and in abundances of key astrocytic proteins for hippocampus, cortex and striatum. However, the cerebellar proteome stands out with proteins being highly associated with the calcium signaling pathway or with bipolar disorder. Subregional analysis of single astrocyte TAMRA intensities in hippocampal layers indicates distinct subregional heterogeneity of astrocytes and highlights the applicability of our toolbox to study differences of astrocytic proteomes in vivo.

14 November 2023 in Brain Research
Verified
Journal Article
Closed access
AFAnllely Fernandez
Anllely Fernandez
KCKatherine Corvalan
Katherine Corvalan
OSOctavia Santis
Octavia Santis
MMMaxs Mendez-Ruette
Maxs Mendez-Ruette
ACAriel Caviedes
Ariel Caviedes
UWUrsula Wyneken
Ursula Wyneken